JYJia You

Jia You

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jia You has a total of 11 co-authors. Here are the top co-authors by number of shared publications:

  • Jingyuan Xiong

    West China School of Public Health and West China fourth Hospital, Sichuan University, Chengdu, China

    2 shared publications
  • Chaoxiong Zhang

    Healthy Food Evaluation Research Center, West China School of Public Health and West China Fourth Hospital, Sichuan University, 16 Renminnan Road 3rd Section, Chengdu, 610041, Sichuan, China

    1 shared publication
  • Chenghui Li

    Healthy Food Evaluation Research Center, West China School of Public Health and West China Fourth Hospital, Sichuan University, 16 Renminnan Road 3rd Section, Chengdu, 610041, Sichuan, China

    1 shared publication
  • Guochen Ma

    Sichuan Univ, West China Sch Publ Hlth, Hlth Food Evaluat Res Ctr, Chengdu 610041, Peoples R China

    1 shared publication
  • Jiayi Chen

    Healthy Food Evaluation Research Center, West China School of Public Health and West China Fourth Hospital, Sichuan University, 16 Renminnan Road 3rd Section, Chengdu, 610041, Sichuan, China

    1 shared publication
  • Qixue Bao

    Department of Occupational Health and Environmental Hygiene, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, China

    1 shared publication

Latest Publications

  • Open Access

    Human antigen R affects the migration and invasion of human lung cancer A549 cells and regulates E-cadherin suppressor Snail

    by Shufang Shan, Qixue Bao, Guochen Ma, Yuqin Yao, Jingyuan Xiong, Jia You

    Recent studies demonstrated that the progression and metastasis of lung cancer were associated with human antigen R (HuR), a post-transcriptional RNA-binding protein that stabilize and regulate the expression of many tumor-related genes. Although HuR was shown to affect the expressions of epithelial cadherin (E-cadherin), a tumor migration suppressor, in airway epithelial cells, esophageal squamous and colon cancer cells, direct evaluation for the effect and mechanism of HuR on the migration and invasion of lung cancer cells is not documented. In this study, HuR was knocked down via RNA interference and overexpressed using recombinant plasmid in adenocarcinomic human alveolar basal epithelial A549 cells. No apparent inhibition of cell viability was observed. HuR knocked down significantly suppressed A549 migration and invasion in scratch wound healing and transwell assays, with an increase in E-cadherin expression, while the overexpression of HuR notably facilitated A549 migration and invasion, with a decrease in E-cadherin level. In addition, immunoprecipitation study showed that HuR directly interacted with Snail, a repressor of E-cadherin, and upregulated the expression of Snail in A549 cells. These combined results suggested that the effect of HuR on A549 migration and invasion was realized by stabilizing and increasing the expression of Snail, which in-turn interfered with the expression of E-cadherin. The finding of this study revealed direct evidence that HuR affected the migration and invasion of lung cancer cells via regulating E-cadherin and Snail, providing an additional reference and mechanistic clue for further researches and therapeutic strategies in treating lung cancer.


  • Application of the Tumor Site Recognizable and Dual-Responsive Nanoparticles for Combinational Treatment of the Drug-Resistant Colorectal Cancer

    by Ying Shi, Shufang Shan, Chenghui Li, Xuejiao Song, Chaoxiong Zhang, Jiayi Chen, Jia You, Jingyuan Xiong

    Purpose Combination of PCI and chemotherapy represents a promising strategy for combating drug resistance of cancer. However, poor solubility of photosensitizers and unselectively released drugs at unwanted sites significantly impaired the treatment efficacy. Therefore, in the present study, we aimed to develop a nano-platform which could efficiently co-entrapping photosensitizers and chemotherapeutics for active targeting therapy of drug resistant cancers. Methods Two pro-drugs were respectively developed by covalently linking the Ce6 with each other via the GSH-sensitive linkage and the PTX with mPEG-PLA-COOH through the ROS sensitive-linker. The dual-responsive nanoparticles (PNP-Ce6) was developed by emulsion/solvent evaporation method and further modified with tLyp-1 peptides. Physicochemical properties of nanoparticles were determined by the TEM and DLC. Cellular uptake assay was investigated with the Ce6 acting as the fluorescent probe and cell growth was studied by the MTT experiment. In vivo tumor targeting and anti-tumor assay was investigated on the colorectal cancer-bearing mice. Results The developed tPNP-Ce6 were stable enough under the normal physiological conditions. However, free Ce6 and PTX were completely released when exposed the tPNP-Ce6 to the redox environment. Excellent tumor-targeting drug delivery was achieved by the tPNP-Ce6, which in turn resulted in satisfactory anit-tumor effect. Of great importance, super inhibition effect on tumor progress was achieved by the combination therapy when compared with the group only received with chemotherapy.. Conclusion The results obtained in the present study indicated that the developed tPNP-Ce6 may have great potential in enhancing the therapeutic efficacy of drug-resistant colorectal cancer. Left: Targeting delivery of drug to tumor site by the tumor recognizable and dual-responsive nanoparticles and penetrating into tumor inner via the mediation of irradiation. Right: Nanoparticle distribution within tumor tissues with green represents the blood vessels stained with CD31, blue signal represents the cell nuclei stained with DAPI and red shows fluorescence of Ce6 as the indicator of the nanoparticles.